Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$35.68 - $44.71 $449,068 - $562,720
12,586 Added 1.64%
781,140 $32.2 Million
Q3 2022

Nov 14, 2022

BUY
$42.51 - $54.02 $3.56 Million - $4.52 Million
83,628 Added 12.21%
768,554 $33.7 Million
Q2 2022

Jul 20, 2022

SELL
$46.84 - $59.75 $790,659 - $1.01 Million
-16,880 Reduced 2.41%
684,926 $33.7 Million
Q1 2022

Apr 14, 2022

BUY
$48.09 - $57.79 $5.38 Million - $6.47 Million
111,871 Added 18.96%
701,806 $39.8 Million
Q4 2021

Jan 19, 2022

BUY
$47.19 - $62.68 $27.8 Million - $37 Million
589,935 New
589,935 $31 Million
Q2 2021

Aug 09, 2021

SELL
$64.02 - $71.72 $26.1 Million - $29.2 Million
-407,544 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$53.26 - $68.08 $21.7 Million - $27.7 Million
407,544 New
407,544 $26.7 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.